BSI-507

N/A

Report date: 2023/05/19 14:21:01

Base Information

Drug NameBSI-507
Drug Alias NameBSI-507
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-PD-1Transmembrane protein PVRIG antagonists
TargetsProgrammed cell death protein 1Transmembrane protein PVRIG
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBiosion Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiosion Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A